This modification promotes the ubiquitination of LSD1 and its proteasomal degradation and, as described for gastric cancer cells, can stimulate sensitivity to chemotherapeutics, like 5-fluorouracil and oxaliplatin [182]. Here, KDM1A is linked to gastric cancer.